miércoles, 12 de septiembre de 2018

Draft Recommendation Statement and Draft Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

Opportunity for Public Comment - US Preventive Services Task Force
U.S. Preventive Services Task Force banner

Draft Recommendation Statement and Draft Evidence Review:

Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on ocular prophylaxis for gonococcal ophthalmia neonatorumAfter reviewing the evidence, the Task Force recommends prophylactic ocular topical medication for all newborns for the prevention of gonococcal ophthalmia neonatorum. The draft recommendation statement and draft evidence review are available for review and public comment from September 11, 2018 to October 9, 2018 here.
The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment
review and comment

COMMENTING DETAILS

Public Comment Period:

9/11/18 - 10/9/18

Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population
Recommendation
Grade
Newborns
The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum.
A

WHERE WE ARE IN THE PROCESS

Draft Research Plan
Final Research Plan
Draft Recommendation / Draft Evidence Review
Final Recommendation / Evidence Summary

No hay comentarios: